<DOC>
	<DOCNO>NCT02740894</DOCNO>
	<brief_summary>Not significantly increase survival T/T</brief_summary>
	<brief_title>Can Epidermal Growth Factor Receptor Improve Postoperative Survivorship Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>NSCLC spinal metastasis brain metastasis expect survival &lt; 3 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>